[ET Net News Agency, 12 August 2021] SINO BIOPHARM (01177) fell 2.92% to HK$6.65,
dipping below the 10-D SMA of HK$6.807.
It hits an intra-day low of HK$6.63, and an intra-day high of HK$6.82. The total shares
traded was 17.22 million, with a value of HK$115.58m. The active buy/sell ratio is 31:69,
with net selling turnover of HK$42.97m. CHINA INV INFO accounts for greatest net
responsive buying turnover of HK$9.35m, with volume weighted average price of HK$6.71.
MERRILL LYNCH FE accounts for greatest net responsive selling turnover of HK$4.88m, with
volume weighted average price of HK$6.715. The stock has fallen a combined 3.76% over the
past 2 consecutive trading days.
The Hang Seng Index now fell 112 points, or 0.42% to 26,547; the Hang Seng China
Enterprises Index now fell 62 points, or 0.65% to 9,485; the Hang Seng TECH Index now fell
43 points, or 0.63% to 6,777; with an overall turnover of HK$27.44b.
The SSE Composite Index now fell 7 points, or 0.2% to 3,525, with an overall turnover of
RMB148.58b.
The SZSE Component Index now fell 41 points, or 0.28% to 14,979, with an overall
turnover of RMB101.08b.

Basic Information
-------------------------------------------
Nominal 6.650 % Chg -2.92%
High 6.820 Low 6.630
Shares Tr 17.22m Turnover 115.58m
10-D SMA 6.807 %H.V 34.015
20-D SMA 6.826 VWAP 6.713
50-D SMA 7.386 RSI14 39.035
-------------------------------------------
Status: Dipping below the 10-D SMA, active buy/sell ratio is 31:69, with net selling
turnover of HK$42.97m, falling a combined 3.76% over the past 2 consecutive
trading days

Table: Performance of stocks in the same sector or of relevance

Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
SINO BIOPHARM (01177) 6.65 -2.92
SIHUAN PHARM (00460) 2.51 -1.95
TRAD CHI MED (00570) 4.32 +2.13
CMS (00867) 17.18 +0.47
CSPC PHARMA (01093) 10.96 -0.72
3SBIO (01530) 7.22 -0.69
LUYE PHARMA (02186) 4.12 -1.44
FOSUN PHARMA (02196) 58.50 -3.07
WUXI APPTEC (02359) 160.20 -2.08
PHARMARON (03759) 173.90 +1.10
-------------------------------------------------
(ed)